Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAMBA EU Femoropopliteal Trial

NCT01139177 is registered in ClinicalTrials.gov with NovoStent Corporation as lead sponsor.

NCT NCT01139177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01139177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAMBA EU Femoropopliteal Trial
Lead sponsor
NovoStent Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2009
Completion date
September 30, 2010
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease